Navigation Links
The Politics of Pharma: Washington, States, and the Court's Impact on the Industry
Date:4/19/2013

DUBLIN, April 19, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "The Politics of Pharma: Washington, States, and the Court's Impact on the Industry" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Politics have a greater direct effect on the pharmaceutical industry than almost any other in the US, and correspondingly, pharma makes considerable investments in election campaigns. The November elections kept the face of Washington the same, with the re-election of President Obama, Democratic control of the Senate and Republican control of the House. However, the outcome of the elections will still impact the industry in a variety of ways.

The Medical Device Excise Tax, a component of the 2010 health care reform legislation, survived a pre-election Congressional effort at repeal, but a coalition of House Republicans and Democrats from key states are looking to try again. Post-election, another bi-partisan congressional group is pushing for the FDA to impose stricter regulations on certain painkillers. Meanwhile, the Administration's prioritization of generics at the FDA remains controversial.

The budget impasse and resulting sequestration are election fall-outs that may impact the pharmaceutical industry in a number of ways: decreased vaccine sales, reduced research funding and potential cuts at the FDA that could dramatically raise time to market. Medicare reform also looms out as an issue un-resolved in November, with the possibility of playing a role in the mid-term elections

The report The Politics of Pharma was written to provide companies with an update and future outlook of how the political atmosphere within the United States will impact the pharmaceutical industry in both the near and long term. This report should be used by both large and small organizations alike, as well as branded and generics manufacturers.

Key Reasons to Purchase

- Understand the current pharmaceutical related issues before the Supreme Court
- Assess the impact of the November elections on the political issues that affect pharma now and in the future
- Evaluate where pharmaceutical companies should turn their political focus
- Analyze why state politics are increasingly important to pharmaceutical companies and the impact they could have on future revenues
- Examine the potential impact from the current budget impasse
- Benefit from accessing CBR's view on the outlook for the pharmaceutical industry as a result of the political climate in the United States

Key Topics Covered:

Executive Summary

Chapter 1: November Election Results

- Pharma's investment in the elections
- Election results
- Medical device tax
- Congressional spotlight on painkillers
- The FDA


Chapter 2: Health Care Reform

- Implementation
- The Sunshine Act
- Meaningful use debate


Chapter 3: State Politics

- State Health Care Exchanges
- Biosimilar substitution


Chapter 4: The Courts

- Pay-for-delay
- Generics liability
- Reform
- Off-label use


Chapter 5: The Political Outlook

- Impact of the budget impasse
- Medicare
- Indian trade issues
- The CBR View


For more information visit The Politics of Pharma: Washington, States, and the Court's Impact on the Industry

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ActualMeds Debuts With The Hive as Part of TEDMED 2013 Washington, DC, April 16-19, 2013
2. Equatorial Guineas [EG] Ministry of Health convenes in Washington, DC with GB Group Global and TNI Biotech (OTCBB:TNIB) to launch major innovative health solutions and improve pharmaceutical quality for its citizens
3. Medicaid Managed Care Drug Rebates Saved States, Feds $1.6 Billion in First Year
4. Alternate Distribution Channels Claim Opportunities for OTC Drug Sales in the United States, Finds Kline
5. ESAs and a New Class of Late Stage Oral HIF-PH Inhibitors May Be Impacted by the Fact That Nephrologists Report Initiating ESAs at Lower Hemoglobins
6. National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration
7. Cellular Dynamics Announces Presentations at the Society of Toxicologys 52nd Annual Meeting Demonstrating the Expanding Impact of iPSC-Derived Human Cells on Toxicology Assay Development
8. Impact of Geographic Location on Weight Loss Considered by Makers of Hydroxycut
9. Thomson Reuters Spotlights the Impact of Personalized Medicine on Pharmaceutical R&D
10. Polymers in Medical Devices: Opportunities Arising and Trends Impacting the Market
11. High-Impact Recalls -- Building a Process to Avoid Disaster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):